six patients were alive and disease-free. The median survival after IA diagnosis was 36 days. Of eight variables found to be related to survival according to the univariate analysis, graft-versus-host disease (GVHD) status at IA diagnosis (P Å .0008) and the cumulative prednisolone dose taken during the week preceding IA diagnosis (CPD1w) (P õ .0001) were selected by a backward stepwise Cox regression model. A three-stage classification was established: CPD1w of £7 mg/kg (3 of 8 patients died; 60-day survival rate, 88%), CPD1w of ú7 mg/kg and no GVHD (9 of 10 patients died; 60-day survival rate, 20%), and CPD1w of ú7 mg/kg and active acute grade 2 or more or extensive chronic GVHD (9 of 9 patients died; 30-day survival rate, 0) (P õ .0001).
Survival and Prognostic Factors of Invasive Aspergillosis After Allogeneic Bone Marrow Transplantation
lated to patient characteristics and treatments, both prior to and Invasive aspergillosis (IA) is becoming a leading cause of at the time of IA. death due to infection after allogeneic bone marrow transplantation (BMT). This increased incidence is not completely understood; it may reflect the intensification of preparative regimens to avoid rejection or relapse and/or result from the intensificaPatients and Methods tion of immunosuppressive therapy given to prevent or treat graft-versus-host disease (GVHD) in the setting of mismatched Patients or unrelated transplants. Furthermore, patients may now be
We reviewed the medical records of all patients who develreferred to BMT centers after having been more heavily preoped IA between January and September 1994. treated than before according to the recent chemotherapy proto-
The BMT unit at Hôpital Saint-Louis, Paris, consists of 19 cols for leukemia or lymphoma; these patients, who have had high-efficiency particulate air -filtered rooms including 16 lamprotracted phases of neutropenia, may have a higher chance inar airflow (LAF) rooms. Eighty to 90 BMTs are performed of being colonized by Aspergillus species before BMT. The yearly. Patients were admitted 2 weeks before transplantation. increased incidence of IA, usually a late infection after BMT, Baseline evaluation included lung and CNS CT. Patients were may also be due to better control of early complications, such conditioned and given prophylaxis for GVHD according to as bacterial and cytomegalovirus (CMV) infections. Moreover, their underlying disease and to the transplant type. At entry, physicians may now be more aware of the clinical characterisprophylaxis for infection consisted of amoxicillin (1,500 mg/d), tics of this infection and diagnose it earlier.
pefloxacin (800 mg/d), fluconazole (400 mg/d) together with From the beginning of 1994 to late October 1994, we oboral amphotericin B (1,500 mg/d), intravenous acyclovir (15 served 27 cases of IA; the ward was temporarily closed for mg/[kgrd]), and trimethoprim-sulfamethoxazole (30 mg of sulcleaning and renovation at the end of September 1994. This famethoxazole/kg three times a week) or sulfadoxine/pyrimethstudy estimated the survival of bone marrow transplant recipiamine (15 mg of pyrimethamine once a week). For children, ents with IA and identified prognostic factors for survival rethese dosages were adapted to body weight.
Patients with fever and granulocytopenia were managed with empirical therapy with broad-spectrum antibiotics and intravenous amphotericin B as indicated [1] . Therapy with all antiin-considered to have antigenemia when at least two consecutive Before IA diagnosis, potential prognostic factors were as follows: age; gender; underlying disease; disease status; CMV tests were positive.
Patients with acute GVHD were treated with prednisolone serology; type of transplant (matched related, matched unrelated, mismatched related, or second); preparative regimen; at an initial dosage of 2 mg/(kgrd). The dosage was increased to §5 mg/(kgrd) in the case of disease progression. Some interval between BMT and IA; cumulative prednisolone dose during the week (CPD1w), 2 weeks (CPD2w), and 4 weeks nonresponding patients were given a 5-to 7-day course of antithymocyte globulin (ATG) therapy according to current (CPD4w) preceding IA diagnosis; total cumulative prednisolone dose; having taken a daily prednisolone dose of §5 protocols. Patients were discharged from the unit when they had an ANC of ú500/mL and no active GVHD and the daily mg/(kgrd) at some time and/or ATG therapy (both treatments given either during the interval between BMT and IA or, for prednisolone dose was õ2 mg/kg. Patients with extensive chronic GVHD were usually treated on an outpatient basis with cases occurring ú6 months after BMT, during the last 6 months); and when ATG treatment was prescribed, interval prednisolone and cyclosporin A.
between ATG treatment and IA. Potential prognostic factors at the time of IA diagnosis in-
Definition of Cases
cluded the following: ANC; concomitant CMV infection or Bronchoalveolar lavage (BAL) was performed at the padisease; CNS involvement; extent of CT-assessed lung lesions tient's bedside as soon as possible in the case of clinical (or (unilateral and single, unilateral and multiple, or bilateral and roentgenographic) suspicion of IA. A thoracic CT was also multiple); active acute grade 2 or more GVHD or extensive performed, even in the setting of neutropenia, when the lung chronic GVHD; prednisolone dose on the day of IA diagnosis; image was suggestive of IA (an air-crescent sign in the cavity renal insufficiency (defined as a serum creatinine level twice or a halo sign around the nodule). A brain CT or, whenever the normal upper value [NUV]); serum alkaline phosphatase possible, MRI was obtained at the same time. Needle aspiravalue (less than or three or more times the NUV); and type of tions and/or biopsies of the skin or of an otherwise sterile site IA diagnosis (definite or probable). Finally, we recorded the were performed when indicated.
highest fibrinogen value during the 15 days after IA diagnosis. Patients were classified as having definite pulmonary IA when there was a suggestive CT and fungal hyphae were observed directly in BAL fluid or two consecutive sputum sam-
Statistical Analysis
ples, or when culture of these specimens were positive for Survival was estimated by using the Kaplan-Meier method, fungi, or both. The diagnosis of probable pulmonary IA was and prognostic significance of covariates was studied by means based only on a suggestive CT. A definite sinus infection was of a two-sided logrank test with a type I error of .05. All defined as a positive sterile-needle aspirate or biopsy specimen variables found to have a P value of õ.05 were introduced and a consistent CT. A probable sinus infection was defined as binary covariates into a backward stepwise Cox regression as a consistent CT in the setting of another site positive for model. Relative risk (with its 95% confidence interval) was fungi. Positive cultures were not required when examination estimated by using the Cox regression model. SAS software of smears or biopsy specimens revealed fungal hyphae.
(SAS Institute, Cary, NC) was used.
Antifungal Treatment Strategy
Twelve patients were treated with conventional amphotericin Results B (amphotericin B deoxycholate) with or without flucytosine.
Sample Size and Patient Characteristics
Six patients received the liposomal formulation AmBisome (Vestar, San Dimas, CA NOTE. AD Å advanced disease; AL Å acute leukemia; ATG Å antithymocyte globulin; CML Å chronic myeloid leukemia; CMV Å cytomegalovirus; CP1 Å first chronic phase; CPD1w, CPD2w, and CPD4w Å cumulative prednisolone dose during the week, 2 weeks, and 4 weeks preceding IA diagnosis, respectively; CR1 Å first complete remission; FTBI Å fractionated total body irradiation; IA Å invasive aspergillosis; MDS Å myelodysplastic syndrome; NHL Å non-Hodgkin's lymphoma.
* Log rank test.
Clinical and Mycological Data
Presumed CNS involvement was diagnosed on the initial CT or MRI for 11 patients (41%). Abdominal involvement was not Diagnostic procedures, type of diagnosis, and mycological systematically investigated. However, patient 12 had a biopsydata (table 2) . Seventeen (63%) of 27 patients had an eleproven gastric infection, patient 6 had autopsy-proven involvevated body temperature (ú38ЊC) at the time of IA diagnosis. ment of the spleen and kidneys, and patients 4 and 22 had CT Overall, 20 infections were classified as definite, and seven findings suggestive of liver (2 patients), spleen (2), or kidney were classified as probable. Radiological evidence of lung (1) involvement. involvement was recorded in 24 cases (89%). Twenty-one paSeventeen patients underwent BAL, and this procedure tients (74%) had lesions highly suggestive of aspergillosis on yielded positive results for 14 (smear alone, 2; culture alone, lung CTs (halo sign, 15 patients; air-crescent sign, seven pa-4; both smear and culture, 8), with 13 having a pattern on the tients). Eight patients (30%) had clinical symptoms of sinusitis, CT that was highly suggestive of lung involvement. Moreover, while 11 patients (41%) had CT findings suggestive of sinusitis. patients 6, 12, 13, and 20 had one or more additional proven Five patients (19%) had a pleural effusion. Two patients had sites of infection. Patient 3, for whom BAL was positive, had multiple consolidations and ground-glass opacifications tobronchoscopic evidence of tracheal involvement.
/ 9c61$$fe30
01-20-99 07:12:43 cida UC: CID NOTE. ACS Å air-crescent sign; B Å bilateral; BAL Å bronchoalveolar lavage; GI Å gastrointestinal; HS Å halo sign; IA Å invasive aspergillosis; ND Å not determined; UM Å unilateral and multiple; US Å unilateral and single.
* At least two positive serum specimens. † Autopsy-proven.
gether with high titers of Aspergillus antigen in the blood. Two 19), and sinus aspiration (patient 18, who also had antigenemia) or biopsy (patient 15). patients, for whom BAL was noncontributive, had either a halo sign on the lung CT and two positive sputum samples (patient There were seven cases without mycological documentation. Six of these seven patients with probable disease had more 26) or a positive skin biopsy sample (patient 13).
Ten patients did not undergo BAL, mainly because of clinithan one suspected site of infection, a pattern on the CT that was highly suggestive of lung involvement, and antigenemia. cal and radiological evidence of IA and too poor general condition, including mental confusion (seven patients). Mycological Patient 1 was classified as having probable brain aspergillosis on the basis of the association of multiple low-density lesions identification was obtained for four of these patients by sputum examination (patient 11, with a halo sign on the lung CT), with no contrast enhancement on the brain CT and rapidly increasing titers of Aspergillus antigen in the blood. pleural fluid examination and lung wedge resection (patient / 9c61$$fe30 01-20-99 07:12:43 cida UC: CID (table 3) . The last death due to or with aspergillosis ococcurring ú1 year after BMT, had not been readmitted to the BMT unit for ú3 months. The median time between the first curred on day 55 after IA diagnosis, and the last death in this series occurred on day 347. The median survival after IA symptom of the fungal infection and its diagnosis was 4 days (range, 0 to 61 days), and this time was ú7 days for 10 patients. diagnosis was 36 days. Six patients were alive without any symptoms of aspergillosis. These patients have been followed Patient characteristics at the time of IA diagnosis (tables 3 and 4). The median ANC was 2,500/mL (range, 0 to 9,300/mL).
up for a median of 1,169 days (range, 1,100 to 1,334 days). Thus, the 1-year overall survival rate was estimated to be 22% Only five patients had an ANC of £500/mL. Twenty patients (74%) had had acute GVHD of grade 2 or more (grade 2, 10 (95% CI, 6% -38%) (figure 1). IA was the primary cause of death in 14 patients. It was patients; grade 3, 7; grade 4, 3) that was still active in seven at the time of IA diagnosis. Five patients had developed extensive chronic associated with active GVHD in seven patients and other uncontrolled problems in four. However, IA was the only cause GVHD that was still active in four. The median prednisolone dose at the time of IA diagnosis was 1.2 mg/kg (range, 0 to 5 mg/kg).
of death in three patients who died primarily of CNS involvement. Four additional patients died with aspergillosis as a conEleven patients had a concomitant CMV infection diagnosed by / 9c61$$fe30 01-20-99 07:12:43 cida UC: CID Applying these two parameters to our population, a three-stage (or extensive chronic) GVHD (9 of 9 patients died; 30-day
survival rate, 0) (P õ .0001) (figure 2). The relative risk of active GVHD who had received ú7 mg/kg.
tributive cause of death. Overall, 18 patients died of or with Discussion aspergillosis, including five terminally ill patients who had massive hemorrhage (lung, 3 patients; gastrointestinal tract, 1;
IA has become a major threat after allogeneic BMT. From and CNS, 1). Three deaths were not related to IA and occurred January to October 1994, 27 consecutive IA cases were diag-ú3 months after the infection had been diagnosed (patients nosed in our BMT unit. If we consider only the patients who 19, 20, and 27).
underwent transplantation during the same period, 16 (24%) of 68 contracted this fungal infection. Compared with the rate of 8% -10% that had been observed during the preceding 5
Prognostic Factors for Overall Survival years, this rate represents an increase in incidence. These fungal infections were both early (first LAF isolation) and late compliUnivariate analysis. Twenty-five covariates were studied (tables 1 and 4); pretransplantation variables did not influence cations of transplantations. We are unable to provide any definite explanation for this increase. Twenty cases of IA were defined as definite, and seven between day 48 and day 100 at the City of Hope National Center (Duarte, CA) [4] , and 2 months in the series by Winwere defined as probable. Only six patients (including the two patients for whom autopsy data were available) had histologigard et al. [5] . This interval means that, at the time of diagnosis of the fungal infection, most patients were being followed cally proven aspergillosis. However, we think that it is very unlikely that the other patients did not have IA because most up on an outpatient basis. Studying 158 IA cases that had occurred in 2,496 patients (including 488 autologous or syndiagnoses were based on the association of a highly suggestive CT and isolation of Aspergillus or a highly suggestive CT and geneic transplant recipients) who underwent transplantation at the Fred Hutchinson Cancer Research Center (Seattle, antigenemia. The EIA that we used for antigen detection has been shown to have a specificity of 80% [2] . Furthermore, WA) between January 1987 and June 1993, Wald et al. [6] observed that the time to development of IA after transother mold infections are extremely infrequent in this setting; fusarium infections have a different clinical presentation, are plantation was bimodal, with the first peak at a median of 16 days and the second peak at a median of 96 days. The usually diagnosed with blood cultures, and are not associated with false-positive results of antigenemia [2] . median time to diagnosis for the 144 patients with allogeneic transplants was 64.5 days (interquartile range, 26 to 92 days). IA is usually a late infection after BMT: the median time to development was 100 days after grafting in this series, Sixty-one percent of the infections occurred ú40 days after BMT. By multivariate Cox regression, LAF rooms (where 90 days in a previous series from our institution [3] , mostly (upper curve) Å patients with CPD1w of £7 mg/kg (n Å 8; 3 deaths); rrrr (middle curve) Å patients with CPD1w of ú7 mg/kg and no active GVHD (n Å 10; 9 deaths; median survival, 44 days); and ---(lower curve) Å patients with CPD1w of ú7 mg/kg and active GVHD (n Å 9; 9 deaths; median survival, 7 days) (P õ .0001 [logrank test]).
01-20-99 07:12:43 cida UC: CID 69 of 158 patients were placed) were protective for early dismal outcome, with a reported mortality rate of nearly 100% [8] . No patient with brain involvement in this series survived (õ40 days) but not late infections.
This observation is in agreement with the two main mecha-ú52 days, and this site of infection was strongly associated with death by the univariate analysis. However, the multivariate nisms of protection against aspergillosis: alveolar macrophages and granulocytes [7] . Indeed, recovery from granulocytopenia analysis did not show that brain involvement was an independent factor. usually allows discharge from the protected environment but does not rule out the major risk due to persisting macrophage
We found that active acute grade 2 or more or extensive chronic GVHD and a CPD1w of ú7 mg/kg were the predomiimpairment. We did not observe a bimodal distribution of the time to IA following transplantation, but all our patients were nant poor prognostic factors. Moreover, the combination of these two parameters further characterized three groups of paplaced in LAF rooms for transplantation.
The median survival time for our patients was 36 days. The tients with 60-day survival rates estimated at 88%, 20%, and 0, respectively. The major implication of the steroid dose is crude mortality rate was 78% (exact 95% CI, 58% -91%). Six patients are long-term survivors with a minimal follow-up on understandable in light of their known inhibitory effect on the polymorphonuclear leukocyte -induced damage of fungal 30 September 1997 of 1,100 days. Previously reported mortality rates for this category of patients were as follows: 94% hyphae and the conidiacidal activity of tissue macrophages [20, 21] . Moreover, hydrocortisone has recently been shown (102 of 109) in the review by Denning and Stevens (which included some autologous BMTs) [8] and, more recently, 95%
to induce a 30% -40% increase in the rate of in vitro growth of A. fumigatus and A. flavus [22] . This effect was shown to (19 of 20) [9] , 94% (15 of 16) [10], and 91% (84 of 92) [11] . Several factors may explain our reduced mortality rate be dose-dependent with a concentration of 10 06 M that corresponded to the maximum growth increase. In addition, it has including better knowledge of risk factors [4, 6, 10, 12 -15] and clinical manifestations [8, 16] and routine availability of been shown that a concentration of dexamethasone of 10 06 M was achievable in vivo with doses of prednisone of §1 such tools as CT and MRI. These advances lead to earlier diagnosis and treatment. The median time between the first mg/kg [23] .
Although there is an obvious relationship between GVHD clinical symptom and diagnosis was estimated at 4 days in this series.
activity and steroid dose, our study supports that GVHD has additional influence as a poor prognostic factor. This finding Caillot et al.
[17] studied 37 patients with hematologic malignancies and IA and reported that the time to diagnosis was may be another illustration of the intrinsic immunosuppressive properties of GVHD [24] . This analysis further indicates that, shorter after October 1991 than before (1.9 vs. 7 days, respectively). The shortened time to diagnosis was associated with a while treating patients with acute or chronic GVHD, the dilemma of decreasing the steroid dose (to decrease the risk of better prognosis. It is anticipated that the routine use of techniques such as detection of Aspergillus antigens in blood or aspergillosis as much as to improve the prognosis of this infection, if it occurs) must be faced without worsening GVHD. other biological fluids (BAL fluid, CSF, etc.) and Aspergillus DNA in the same fluids will facilitate diagnosis [2, 18] .
Our findings confirm preliminary results [25] . Although the sample size was small, this series was homogeneous: all these Recovery from granulocytopenia, achievement of a hematologic response, early diagnosis, unilateral pulmonary involveconsecutive patients were diagnosed and treated in the same BMT unit during a limited period. Very recently, GVHD and ment, and a highest fibrinogen value of õ9 g/L have been reported to be associated with a better outcome of IA in patients receiving a methylprednisolone dose of §1 mg/kg were reported to be associated with poor outcome for bone marrow with hematologic malignancies, most of whom had acute leukemia [14, 17, 19 ]. We could not find a relationship between or peripheral blood stem cell transplant recipients with IA [26].
In conclusion, since IA is most often a late infection after ANC at the time of IA diagnosis and the duration of neutropenia after diagnosis and outcome. However, at diagnosis, only five allogeneic BMT, outbreaks of this infection will likely continue to occur until effective prophylactic antifungal regimens and/or and two patients had an ANC of õ500/mL and õ100/mL (median ANC: 2,500/mL at diagnosis in this series and 1,400/mL better prevention of GVHD become available. Overall survival remains poor; however, cures have been observed with proin our previous study [3] ), respectively. Unlike Caillot et al.
[17], we could not establish a prognostic value for the extent longed antifungal treatments. The CPD1w and GVHD status at the time of diagnosis are the two factors that significantly of lung involvement at the time of IA diagnosis or the fibrinogen level in the 2 weeks following IA diagnosis. Again, our affect survival. sample was different.
Brain involvement is frequent in patients who have under-
